The pharmaceutical industry is bracing for potentially major disruptions following US President Donald Trump’s announcement ...

Repatha: the frontline of US price battles Amgen's Repatha became the first in the new class of cholesterol-lowering PCSK9 inhibitor drugs to gain approval this year, getting the nod in Europe in ...

Recent health news includes European agencies monitoring bird flu, a diphtheria death in Berlin, and controversies ...

In the early hours of September 14, 2021, three men parked in a quiet car park in the southern English market town of ...

As more United States drug price changes have come to light this month, it remains clear that companies are tamping down ...

Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper ...

“A 25% tariff on Canada and Mexico threatens to upend the very supply chains that have made U.S. manufacturing more ...

Novo Nordisk's CEO is not worried about blockbuster semaglutide drugs being added to Medicare drug pricing negotiations this ...

Gas inventories are in the spotlight because high summer prices mean it’s currently unprofitable to buy gas to put into ...